# INVOKAMET XR
> **NDA205879** · New Drug Application · Sponsor: JANSSEN PHARMS · Approved 2016-09-20
## Drug
- **FDA Application Number:** NDA205879
- **Application type:** New Drug Application
- **Brand name:** INVOKAMET XR
- **Generic name:** CANAGLIFLOZIN AND METFORMIN HYDROCHLORIDE
- **Active ingredients:** CANAGLIFLOZIN; METFORMIN HYDROCHLORIDE
- **Dosage form:** TABLET, EXTENDED RELEASE
- **Route:** ORAL
- **Marketing status:** Prescription
- **Sponsor:** JANSSEN PHARMS
- **Manufacturer:** Janssen Pharmaceuticals, Inc.
- **First approval:** 2016-09-20
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=205879)
---
*AI Analytics · CC0 1.0*